Navigation Links
Solos Endoscopy to Launch New SteriTAP™ Endoscopic Instrument Line
Date:3/16/2012

BOSTON, March 16, 2012 /PRNewswire/ -- Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce that the Company will be launching a new endoscopic instrument line, SteriTAP™.  Solos' SteriTAP™ Instruments are designed to be the ultimate sterile "take a part" endoscopic instruments of its kind and will be marketed and sold worldwide by Solos Endoscopy.

Solos' SteriTAP™ instruments are also approved to immediately receive the CE Mark, which will allow the product to be marketed in those countries where the CE Mark is required, once Solos Endoscopy receives its proper certifications.  According to Reportlinker, the demand for endoscope services is increasing due to an increase in the aging and chronically ill population worldwide. Advancements in endoscopic technologies and inclusion of various types of lighting sources, video cameras, real-time conversion of data into three-dimensional images are also driving this market. Endoscopy procedures have become highly effective in the diagnosis, treatment, and management of cancer patients. Many now consider endoscopy to have become the gold standard for cancer diagnosis and treatment, as well as for many other medical conditions.

There are other reasons that minimally invasive surgical (MIS) procedures like endoscopy are gaining ground in the overall medical arena. Endoscopic procedures, in general, have a lower cost than their counterparts in traditional surgery. In some cases, the patient only needs light sedation as opposed to full anesthesia. Reduced post surgery monitoring time is required for patients undergoing endoscopic procedures. Finally, there is usually a significantly reduced period the patient has to stay in the hospital along with reduced ancillary costs associated with a post-surgical hospital stay.

The SteriTAP™ Instrument line will be added to the Solos Endoscopy product line assortment, which are all featured on the Company's website: '/>"/>

SOURCE Solos Endoscopy, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Solos Endoscopy, Inc. Successfully Completes Level I FDA Inspection
2. Solos Endoscopy, Inc. Announces Retirement of 150 Million Common Shares
3. Solos Endoscopy, Inc. is Primed for Growth in 2012
4. Solos Endoscopy, Inc. Reports Significant Sales From Its MammoView® Instrument Line
5. Solos Endoscopy Finishes the 3rd Quarter With a Net Profit
6. Solos Endoscopy Poised for Tremendous Growth in Multi-Billion Dollar Endoscopic Market
7. Solos Endoscopy Goes Google
8. Solos Endoscopy Finishes the 3rd Quarter Strong
9. Solos Endoscopy to Support National Breast Cancer Foundation With Sales of Its MammoView® Breast Endoscopy Components to US Hospitals
10. Solos Endoscopy to Market its MammoView® Breast Endoscopy Components to US Hospitals
11. Solos Endoscopy Reports 32% Increase in Breast Endoscopy Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Physician-Patient Alliance for Health & Safety recently released three lessons ... address this issue has been emphasized by The Joint ... alarm safety in hospitals." According to The Joint Commission Sentinel ... were 98 alarm related events reported, of which: ... in permanent loss of function (13%) , 5 resulted ...
(Date:6/19/2013)... June 19, 2013   Voices Against Brain Cancer ... cure for brain cancer, today announced that it has ... support the clinical investigation of Toca 511 & Toca ... glioma brain cancer (Grade 3 or Grade 4).  Tocagen ... for advanced cancer, with an initial focus on brain ...
(Date:6/19/2013)... DIEGO , June 19, 2013   Nektar Therapeutics ... results from a human abuse liability (HAL) study for ... rate of entry into the brain.  This slow rate of ... to the abuse of and addiction to current opioid analgesics. ... NKTR-181 was rated similar to placebo in "drug liking" ...
Breaking Medicine Technology:Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 2Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 3Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 2Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 4Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 5Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 6Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 7Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 8Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 9
(Date:6/19/2013)... As warmer weather arrives and vacations begin, Asheville’s ... summertime packages. , “Whether guests are traveling to Asheville ... staycation, we think that these available packages will offer ... so beautiful in the summertime and there is a ... can choose from, based on their interests, offers something ...
(Date:6/19/2013)... 2013 According to Fastcare ... sun exposure is perhaps the biggest and certainly ... that is just one of many potential factors ... cancer. Other risk factors include:, , ... ,     Heredity may play a role , ...
(Date:6/19/2013)... The benefits, NASS said, ... the overall experience for the majority of those who ... Mr Mouw, whose Virgina-based company enjoys an international clientele, ... saying that the type of sauna is also important. ... counterfeit imitations which frankly, can be extremely dangerous particularly ...
(Date:6/19/2013)... Hollywood, CA (PRWEB) June 19, 2013 ... conditions with little to no access to the medical ... organizations are providing access to health care and the ... of these third-world nations. , Outlook with ... organizations to reveal the conditions in which these people ...
(Date:6/19/2013)... 19, 2013 Daily Gossip issued a press ... method will be published on their website at the ... article to inform readers about the information they will find ... reporters working at Daily Gossip, the article is a review ... , Hiller has understood during the vast research he has ...
Breaking Medicine News(10 mins):Health News:Fun Depot Partners with Brookstone Lodge on Summer Packages 2Health News:Risk Factors of Skin Cancer & Reducing That Risk 2Health News:Risk Factors of Skin Cancer & Reducing That Risk 3Health News:Health Benefits of Saunas Only Viable with Properly Constructed Models, Warns Manufacturer 2Health News:The Jump Manual Review: Reveals Hiller’s Method of Vertical Jump Training 2
... , DENVER, CO , Jan. 28 ... MIT is pleased to announce that it has started ... Jacques Gauthier and Mr. Michel Carrier as members ... has served on the board of directors of Axcan Pharma ...
... , Emergency Relief Fund Established for Haitian ... 28 The Assisted Living Federation of America ... Haitian employees of senior living companies. , "The employees of our ... seniors.  Now, in their hour of need, we offer support to ...
... CAMBRIDGE, Mass. , Jan. 28 DNA ... health through innovation, today announced it has been awarded ... from the National Aeronautics and Space Administration (NASA).  The ... facilitate whole health analysis in a single drop of ...
... part in a study thought that their obese four or five ... fathers, according to the February issue of Acta Paediatrica . ... of mothers and 77 per cent of fathers thought that their ... children took part in the study, carried out by researchers from ...
... innovative cardiac scanner will dramatically improve the process of ... developed at the University of Leeds, with funding from ... a key role. Due to its unprecedented ... to detect a number of conditions, including heart problems ...
... , ... Attempt, George Hood Utilizes Blogging, Facebook, Twitter, and LinkedIn to Raise Awareness, Funds ... Aurora, IL (PRWEB) January 28, ... Ultra endurance athlete is currently training to break the Guinness world record in stationary (spin) ...
Cached Medicine News:Health News:MIT is pleased to announce the nomination of Mr. Jacques Gauthier and Mr. Michel Carrier to its newly formed Advisory Board 2Health News:ALFA Extends Helping Hand to Haiti 2Health News:NASA selects DNA Medicine Institute's Nanoscale Diagnostics Technology for Phase II SBIR 2Health News:Most parents don't realize their 4 or 5 year-olds are overweight or obese 2Health News:Breakthrough heart scanner will allow earlier diagnosis 2Health News:Aurora Man's Guinness World Record Attempt Goes Social 2Health News:Aurora Man's Guinness World Record Attempt Goes Social 3Health News:Aurora Man's Guinness World Record Attempt Goes Social 4
Innotrac Aio! immunoanalyzers are specially designed to exploit the benefits of Innotrac Diagnostics' exclusive dry chemistry and non-enhancement time-resolved fluorometry....
... Synchron LXi 725 clinical system combines ... accurate immunoassay testing capabilities, innovative data ... a single platform. After tests are ... for optimal quality assurance. If reflex ...
... Access immunoassay system is ... benchtop analyzer that performs ... with panels that include ... infectious disease, blood virus, ...
...
Medicine Products: